SBIR/STTR Research Award

A Novel Approach for Real-Time Proteomics in Live Cells

Award identifier f819c4a2319b2653bdcb5acf9afa564791ffcdc889f4cbbc2db24c72ee26610eAwarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$199,995

Program and phase

SBIR · Phase I

Award year

2007

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
POWERHOUSE PROTEOMIC SYSTEMS LLC
Proposal award date
Not reported
Contract end date
Not reported
UEI
DPEJBPD8G1C7
Solicitation number
Not reported
Topic code
Not reported

Research abstract

DESCRIPTION (provided by applicant): The ultimate aim of this project is to develop a novel proteomic system that will enable the real-time expression profiling of proteins in live murine embryonic stem (mES) cells and, ultimately, in differentiated cells derived therefrom. In the first step, a library of clonal mES cell lines will be established, each of which will harbor a single fluorescently-tagged protein. The fluorescence in each cell of a particular clonal line will serve as a reporter for the expression level and subcellular localization of the tagged protein in that cell line. This library of clonal fluorescently-tagged lines can be subjected to quantitative fluorescence microscopy in multi- well live-cell arrays, to enable the simultaneous real-time expression profiling of multiple proteins in live cells under various culture conditions. This Phase I study will be focused primarily on developing as extensive a library in mES cells as is practically possible. Such a 'master' library of fluorescently-tagged mES cell lines can also be manipulated in culture into specific tissue-types such as cardiomyocytes, to create a powerful new system for biomarker discovery and drug-screening relevant to economically important diseases such as cardiovascular disease. Further, these mES cells can also be used for the generation of transgenic mice as and when desired, to extend such studies to live animals. The ultimate aim of this project is to develop a system that will enable researchers to monitor the location and levels of hundreds of proteins simultaneously in living cells. Such a system will be useful in understanding the molecular basis of a number of human diseases, such as cardiovascular disease, neurodegenerative disease and diabetes. Further, such a system can be applied to the development of novel diagnostic tests, identification therapeutic targets and the creation of powerful drug-screening platforms to identify potential therapeutic agents that may cure these diseases.

Technology keywords

Not reported

Other awards by this recipient

Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.

Research funding history

3 SBIR/STTR records share this UEI (2007–2015). Reported award amounts total $1,932,212. Reported amounts are not federal obligations.

Phases: Phase I, Phase II

Agencies: Department of Health and Human Services

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.